Soumit Roy
Stock Analyst at Jones Trading
(1.46)
# 3,220
Out of 4,759 analysts
34
Total ratings
15.38%
Success rate
-5.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMRX Chimerix | Downgrades: Hold | $8.55 | $8.43 | +1.42% | 1 | Mar 6, 2025 | |
| INAB IN8bio | Upgrades: Buy | $1.2 | $0.25 | +386.03% | 4 | Feb 11, 2025 | |
| OKUR OnKure Therapeutics | Initiates: Buy | $32 | $5.02 | +537.45% | 1 | Jan 28, 2025 | |
| MURA Mural Oncology | Initiates: Buy | $16 | $3.62 | +341.99% | 1 | Jan 27, 2025 | |
| CRVO CervoMed | Downgrades: Hold | n/a | $2.21 | - | 2 | Dec 10, 2024 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.64 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $7.89 | +14.07% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $21.00 | +71.43% | 1 | Oct 31, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Buy | $17 | $8.00 | +112.50% | 1 | Oct 31, 2024 | |
| BEAM Beam Therapeutics | Initiates: Hold | n/a | $28.48 | - | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.72 | +655.81% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.80 | +402.45% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.81 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.44 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $8.71 | +198.51% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $30.64 | +128.46% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $28.44 | -64.84% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $5.54 | +369.31% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.69 | +1,206.62% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.91 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $10.59 | +655.14% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.96 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.37 | +2,091.18% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.18 | +15,537.07% | 1 | Feb 24, 2021 |
Chimerix
Mar 6, 2025
Downgrades: Hold
Price Target: $8.55
Current: $8.43
Upside: +1.42%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $1.2
Current: $0.25
Upside: +386.03%
OnKure Therapeutics
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $5.02
Upside: +537.45%
Mural Oncology
Jan 27, 2025
Initiates: Buy
Price Target: $16
Current: $3.62
Upside: +341.99%
CervoMed
Dec 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.21
Upside: -
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.64
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $7.89
Upside: +14.07%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $21.00
Upside: +71.43%
ORIC Pharmaceuticals
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $8.00
Upside: +112.50%
Beam Therapeutics
Sep 17, 2024
Initiates: Hold
Price Target: n/a
Current: $28.48
Upside: -
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.72
Upside: +655.81%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.80
Upside: +402.45%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.81
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.44
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $8.71
Upside: +198.51%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $30.64
Upside: +128.46%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $28.44
Upside: -64.84%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $5.54
Upside: +369.31%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.69
Upside: +1,206.62%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.91
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $10.59
Upside: +655.14%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.96
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $0.37
Upside: +2,091.18%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.18
Upside: +15,537.07%